Rating Change
Barclays analysts reiterated a Equal-Weight rating on Certara, Inc. (NASDAQ:CERT) on August 05, 2026.
reiterateNASDAQ:CERT
Barclays Reiterates Equal-Weight Rating on Certara, Inc. (CERT)
Rating Change Barclays analysts reiterated a Equal-Weight rating on Certara, Inc. (NASDAQ:CERT) on August 05, 2026. Market Context Certara, Inc.
Market Context
Certara, Inc. operates in the Healthcare sector. The stock currently trades at $8.02 with a market capitalization of $1.4B.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Certara, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Certara, Inc.
Among the 10 most recent ratings: 3 Buy, 7 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 05, 2026 | Barclays | Equal-Weight | N/A |
| May 12, 2026 | BMO Capital | Market Perform | N/A |
| May 12, 2026 | Craig-Hallum | Hold | N/A |
| May 12, 2026 | Stephens & Co. | Overweight | N/A |
| May 12, 2026 | Barclays | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View CERT Stock Page
Frequently Asked Questions
What does a Equal-Weight rating mean for CERT?
A Equal-Weight rating from Barclays reflects the analyst's outlook on Certara, Inc. (NASDAQ:CERT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CERT forecast page.